502 related articles for article (PubMed ID: 28642237)
1. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
[TBL] [Abstract][Full Text] [Related]
2. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
3. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
[TBL] [Abstract][Full Text] [Related]
4. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
[TBL] [Abstract][Full Text] [Related]
5. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
6. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
7. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.
Pendse AA; Johnson LA; Kim HS; McNair M; Nipp CT; Wilhelm C; Maeda N
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1436-44. PubMed ID: 22539598
[TBL] [Abstract][Full Text] [Related]
8. S1P2/G12/13 Signaling Negatively Regulates Macrophage Activation and Indirectly Shapes the Atheroprotective B1-Cell Population.
Grimm M; Tischner D; Troidl K; Albarrán Juárez J; Sivaraj KK; Ferreirós Bouzas N; Geisslinger G; Binder CJ; Wettschureck N
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):37-48. PubMed ID: 26603156
[TBL] [Abstract][Full Text] [Related]
9. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
Ishii N; Matsumura T; Kinoshita H; Fukuda K; Motoshima H; Senokuchi T; Nakao S; Tsutsumi A; Kim-Mitsuyama S; Kawada T; Takeya M; Miyamura N; Nishikawa T; Araki E
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
11. Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice.
Wei LL; Ma N; Wu KY; Wang JX; Diao TY; Zhao SJ; Bai L; Liu E; Li ZF; Zhou W; Chen D; Li K
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2070-2083. PubMed ID: 32762445
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
13. Map3k8 Modulates Monocyte State and Atherogenesis in ApoE-/- Mice.
Sanz-Garcia C; Sánchez Á; Contreras-Jurado C; Cales C; Barranquero C; Muñoz M; Merino R; Escudero P; Sanz MJ; Osada J; Aranda A; Alemany S
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):237-246. PubMed ID: 27856455
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
[TBL] [Abstract][Full Text] [Related]
15. Loss of one copy of Zfp148 reduces lesional macrophage proliferation and atherosclerosis in mice by activating p53.
Sayin VI; Khan OM; Pehlivanoglu LE; Staffas A; Ibrahim MX; Asplund A; Agren P; Nilton A; Bergström G; Bergo MO; Borén J; Lindahl P
Circ Res; 2014 Oct; 115(9):781-9. PubMed ID: 25212213
[TBL] [Abstract][Full Text] [Related]
16. Heat shock factor-1 knockout enhances cholesterol 7α-hydroxylase (CYP7A1) and multidrug transporter (MDR1) gene expressions to attenuate atherosclerosis.
Krishnamurthy K; Glaser S; Alpini GD; Cardounel AJ; Liu Z; Ilangovan G
Cardiovasc Res; 2016 Jul; 111(1):74-83. PubMed ID: 27131506
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
[TBL] [Abstract][Full Text] [Related]
18. Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.
Hueso M; De Ramon L; Navarro E; Ripoll E; Cruzado JM; Grinyo JM; Torras J
Atherosclerosis; 2016 Dec; 255():80-89. PubMed ID: 27835742
[TBL] [Abstract][Full Text] [Related]
19. HOXA5 induces M2 macrophage polarization to attenuate carotid atherosclerosis by activating MED1.
Jing Y; Gao B; Han Z; Xin S
IUBMB Life; 2021 Sep; 73(9):1142-1152. PubMed ID: 34117711
[TBL] [Abstract][Full Text] [Related]
20. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
